POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)

Phase 4

Completed

• Conditions: Seasonal Allergic Rhinitis

• Registration Number: NCT00160537
• Lead Sponsor: UCB Pharma

Brief Summary

Comparative study on clinical efficacy and safety of levocetirizine and desloratadine as measured by the subject's satisfaction/dissatisfaction after one week of treatment

Detailed Description

Not available

Study Timeline

• Study Start: 2005-05
• Primary Completion: 2005-07
• Study Completion: 2005-07
• Study First Submitted: 2005-09-08
• Study First Submitted QC: 2005-09-08
• Study First Posted: 2005-09-12
• Status Verified: 2009-09
• Last Update Submitted: 2013-12-13
• Last Update Posted: 2013-12-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Clinical history of SAR known and treated since 2 years.
• Positive skin prick test (wheal > 3 mm larger than the diluent control) or RAST (≥3.5 IU/ml) to grass pollen (less than 1 year).
• Minimum mean T5SS of 8 during the baseline period.

Exclusion Criteria

• Have an associated asthma requiring a daily treatment other than β2 short acting agonist prn
• Have atopic dermatitis or urticaria requiring antihistamine treatment or the administration of oral or topical corticosteroids and any other disease requiring the administration of oral or topical corticosteroids

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Subjects' satisfaction / dissatisfaction after the first week of treatment.

Secondary Outcome Measures

Name	Time	Method
allergic rhinitis symptoms scores over the first week of treatment , subject's satisfaction / dissatisfaction of their choice of treatment after the first week of treatment, time to first feeling of (sufficient) symptom improvement during the first we